References
- Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
- Le Blanc K. Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 2006; 8: 559–61
- Jones BJ, McTaggart SJ. Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp Hematol 2008; 36: 733–41
- Le Blanc K, Frassoni F, Ball L. and Developmental Committee of the European Group for Blood and Marrow Transplantation, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579–86.
- Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 2006; 44: 215–30
- Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003; 121: 368–74
- Cheng FJ, Zou P, Zhong ZD, et al. The growth characteristics of mesenchymal stem/progenitor cells in human umbilical cord blood. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2003; 11: 565–8
- Stute N, Holtz K, Bubenheim M, et al. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 2004; 32: 1212–25
- Doyle A, Griffiths B, Griffiths BJ. Enzymatic techniques for tissue dissociation. Cell and Tissue Culture for Medical Research1st edn. John Wiley and Sons Ltd, Chichester 2001; 29–30